From: Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
Endostar combined with PBDC (TTP, months)
PBDC alone (TTP, months)
T-value
95% CI
P-value
Wang JW 2005[11]
6.3
3.6
T = 12.02
1.815 to 2.91
0.000
Yang L 2005[12]
5.03
3.33
Liu J 2009[17]
6.2
3.4
Shi GY 2009[19]
6.1
3.7
df = 4
Zhang H 2011[24]
7.3
5.1
Mean ± SD
6.19 ± 0.80
3.83 ± 0.73